Acceptance of medications for opioid use disorder in recovery housing programs in Missouri

Wood, Charles M.; Duello, Alex; Miles, Jennifer; Lohmann, Brenna; Gochez-Kerr, Tatiana; Richardson, Kori; Anderson-Harper, Rosie; Winograd, Rachel P.

doi:10.1016/j.jsat.2022.108747

Cited by 8 publications

(2 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other times, persons with OUD are aware of methadone but may delay treatment because of stigma from providers and others ( Woo et al., 2017 ). Furthermore, people taking MOUD may be encouraged to discontinue treatment by abstinence-oriented treatment professionals and healthcare providers ( Madden, 2019 ; Wood et al., 2022 ; Woods and Joseph, 2015 ). Stigma toward MOUD has also been linked with denial of other needed medical services ( Earnshaw et al., 2013 ; Madden, 2019 ; Woods and Joseph, 2015 ; Woo et al., 2017 ).…”

Section: Introductionmentioning

confidence: 99%

Experiences of healthcare and substance use treatment provider-based stigma among patients receiving methadone

Carl

Pasman

Broman

et al. 2023

Drug and Alcohol Dependence Reports

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Experiences of healthcare and substance use treatment provider-based stigma among patients receiving methadone

Carl

Pasman

Broman

et al. 2023

Drug and Alcohol Dependence Reports

View full text Add to dashboard Cite

“…There is little data nationally regarding the extent to which MOUD is accepted in recovery houses. In a recent 2022 cross-sectional study of 64 SAMHSA -funded recovery houses in Missouri, Wood et al (2022) found that 98% allowed at least one of the three FDA-approved MOUD types and only one house allowed all three. (Wood et al, 2022).…”

Section: Introductionmentioning

confidence: 99%

Program, Policy and Social Support Characteristics Associated With Rural vs. Urban Recovery Housing, 2018–2020

Kirby

Kizewski

Thompson³

et al. 2022

Journal of Drug Issues

View full text Add to dashboard Cite

Study objectives were to survey rural and urban recovery house owners/operators on their existing National Alliance for Recovery Residences-like (NARR-like) house programs/policies, and delineate rural–urban differences to raise awareness of NARR standards that align with current recovery house policies/programs and to inform new/enhance existing NARR standards. An electronic survey was developed and disseminated to 112 identified recovery houses in Kentucky. There was a 77% survey response rate. Rural recovery houses were more likely to have provisions in place for persons with disabilities, require clinical services participation, and have a stricter return-to-use policy. Work and/or school requirements in recovery houses were associated with resident stability and house expectations for community integration. Understanding differences in existing NARR-like rural versus urban recovery house policies and programs is necessary to raise state-led NARR affiliate awareness of differential recovery house training and support service needs that can best ready recovery houses for NARR certification.

show abstract

Buprenorphine use among non-hospital residential programs

Nichols,

Baslock,

Sieger

2024

Drug and Alcohol Dependence

View full text Add to dashboard Cite

Acceptance of medications for opioid use disorder in recovery housing programs in Missouri

Cited by 8 publications

References 42 publications

Experiences of healthcare and substance use treatment provider-based stigma among patients receiving methadone

Experiences of healthcare and substance use treatment provider-based stigma among patients receiving methadone

Program, Policy and Social Support Characteristics Associated With Rural vs. Urban Recovery Housing, 2018–2020

Buprenorphine use among non-hospital residential programs

Contact Info

Product

Resources

About